Provided by Tiger Trade Technology Pte. Ltd.

Cue Biopharma, Inc.

25.52
-2.3600-8.46%
Post-market: 25.520.00000.00%19:30 EDT
Volume:101.12K
Turnover:2.66M
Market Cap:185.39M
PE:-0.87
High:28.97
Open:27.48
Low:25.08
Close:27.88
52wk High:45.50
52wk Low:4.97
Shares:7.26M
Float Shares:6.85M
Volume Ratio:0.60
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-29.4600
EPS(LYR):-8.4244
ROE:-1603.48%
ROA:-172.66%
PB:80.25
PE(LYR):-3.03

Loading ...

Cue Biopharma Inc - Expects to Receive $7.5 Mln Payment in May 2026

THOMSON REUTERS
·
Apr 08

Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment From Boehringer Ingelheim Collaboration and License Agreement

THOMSON REUTERS
·
Apr 08

Cue Biopharma Inc - Preclinical Milestone Triggers $7.5 Mln Payment to Cue Biopharma Expected in May 2026 - SEC Filing

THOMSON REUTERS
·
Apr 07

Cue Biopharma triggers $7.5 million milestone payment from Boehringer Ingelheim

Reuters
·
Apr 07

Stocks to Watch: PMGC, Cue Biopharma

Dow Jones
·
Mar 28

Cue Biopharma Inc - Lucinda Warren to Continue as Chief Financial and Business Officer - SEC Filing

THOMSON REUTERS
·
Mar 28

Cue Biopharma appoints Lucinda Warren interim CEO; Usman Azam steps down as president, CEO, director effective March 26, 2026

Reuters
·
Mar 28

Cue Biopharma Inc - Usman Azam Steps Down as President, CEO, and Director Effective March 26, 2026

THOMSON REUTERS
·
Mar 28

Press Release: Cue Biopharma Announces CEO Transition

Dow Jones
·
Mar 28

Cue Biopharma to host virtual R&D Day event; management and KOLs to discuss CUE-401 program

Reuters
·
Mar 26

Cue Biopharma files $300M mixed securities shelf

TIPRANKS
·
Mar 17

Cue Biopharma Inc - May Offer up to $300 Mln of Securities - SEC Filing

THOMSON REUTERS
·
Mar 17

Cue Biopharma Q4 EPS $0.01 Beats $(0.10) Estimate, Sales $21.942M Up From $1.576M Prior Year

Benzinga Earnings
·
Mar 17

Cue Biopharma, Inc. Q4 Operating Expenses USD 19.964 Million

THOMSON REUTERS
·
Mar 17

Cue Biopharma, Inc. Q4 Income From Operations USD 1.978 Million

THOMSON REUTERS
·
Mar 17

Cue Biopharma Inc. Announces Annual Stockholders Meeting

Reuters
·
Mar 17

Cue Biopharma Q4 2025 collaboration revenue rose more than doubled to USD 21.94 million

Reuters
·
Mar 17

Cue Biopharma FY 2025 collaboration revenue more than doubled to USD 27.47 million

Reuters
·
Mar 17

Cue Biopharma to present new in vitro data for CUE-401

TIPRANKS
·
Mar 09

Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026

GlobeNewswire
·
Mar 09